STOCK TITAN

Rockwell Medical (RMTI) CFO awarded 15,000 RSUs and holds 27,239 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Neri Jesse reported acquisition or exercise transactions in this Form 4 filing.

ROCKWELL MEDICAL, INC. SVP and CFO Jesse Neri received a grant of 15,000 shares of common stock as a stock award, rather than an open-market purchase, at a stated price of $0.00 per share. These restricted stock units vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to his continued service to the company.

Effective at 12:01 AM on July 1, 2026, the company completed a 1-for-10 reverse split of its common stock and adjusted outstanding equity awards. After reflecting both the reverse split and this award, Neri directly holds 27,239 shares of Rockwell Medical common stock.

Positive

  • None.

Negative

  • None.
Insider Neri Jesse
Role SVP and CFO
Type Security Shares Price Value
Grant/Award Common Stock 15,000 $0.00 --
Holdings After Transaction: Common Stock — 27,239 shares (Direct)
Footnotes (1)
  1. Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
RSU grant size 15,000 shares Common stock award to SVP and CFO Jesse Neri
Transaction price per share $0.0000 per share Stated price for the RSU grant
Shares held after transaction 27,239 shares Amount of securities beneficially owned following transaction
Reverse split ratio 1-for-10 Reverse split effective July 1, 2026 at 12:01 AM
Vesting schedule 3 equal annual installments On first, second and third anniversaries of July 1, 2026
Restricted stock units ("RSUs") financial
"Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
reverse split financial
"Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.
equity awards financial
"In addition, proportionate adjustments were made to the Issuer's outstanding equity awards."
Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Rockwell Medical (RMTI) report for CFO Jesse Neri?

Rockwell Medical reported that SVP and CFO Jesse Neri received a grant of 15,000 shares of common stock as a stock award. The filing shows this as a compensation-related acquisition, not an open-market purchase, increasing his directly held shares to 27,239 after adjustments.

How many Rockwell Medical (RMTI) shares does CFO Jesse Neri hold after this Form 4?

After the reported transaction and the company’s reverse stock split adjustments, CFO Jesse Neri directly holds 27,239 shares of Rockwell Medical common stock. This figure comes from the Form 4 line titled “Amount of Securities Beneficially Owned Following Reported Transaction(s).”

What are the vesting terms of the 15,000 RSUs granted to Rockwell Medical (RMTI) CFO?

The 15,000 restricted stock units granted to Rockwell Medical’s CFO vest in three equal installments on the first, second, and third anniversaries of July 1, 2026. Vesting is conditioned on his continued service to the company through each applicable anniversary date.

Was cash paid for the Rockwell Medical (RMTI) shares reported in this Form 4?

No cash was paid for these shares according to the Form 4, which lists a transaction price per share of $0.0000. The filing characterizes the event as a grant or award acquisition, indicating a compensation-related equity grant rather than a market purchase.

Did Rockwell Medical (RMTI) implement a reverse stock split affecting this insider holding?

Yes. Effective at 12:01 AM on July 1, 2026, Rockwell Medical effected a 1-for-10 reverse split of its common stock. The company also made proportionate adjustments to outstanding equity awards, and the post-transaction share amount for the CFO reflects this reverse split.

How do the Rockwell Medical (RMTI) RSUs for the CFO depend on continued service?

The RSUs vest only if the reporting person continues serving Rockwell Medical through each vesting date. The footnote states that vesting in three equal installments on the first, second, and third anniversaries of July 1, 2026 is “subject to the Reporting Person’s continued service to the Issuer.”
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neri Jesse

(Last)(First)(Middle)
30142 WIXOM ROAD

(Street)
WIXOM MICHIGAN 48393

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A(1)15,000A$027,239(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer.
2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Remarks:
/s/ Megan Timmins, Attorney-in-fact for Jesse Neri07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)